Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
MVM Partners LLP, founded in 1997, operates from London and Boston. The firm specializes in healthcare and life sciences investments, managing a concentrated portfolio aimed at driving growth through collaboration with management teams. MVM Partners has a significant focus on companies with high growth potential and differentiated technologies.
MVM Partners invests in the healthcare and life sciences sectors, including medical devices, pharmaceuticals, diagnostics, digital health, health IT, life science tools, contract research, and contract manufacturing. They typically write checks ranging from $20 million to $100 million, targeting companies that address significant unmet needs in large markets.
Notable companies in MVM Partners' portfolio include Nalu Medical, acquired by Boston Scientific; Proverum, which received FDA approval for the ProVee System; GT Medical Technologies, known for reducing brain tumor recurrence risk; Paratek Pharmaceuticals, which completed the acquisition of Optinose; and Zimmer Biomet, which acquired Paragon 28.
Email your pitch deck to info@mvm.com for consideration.
Yes, MVM Partners often leads investment rounds, particularly in their focus sectors of healthcare and life sciences.
The firm is open to follow-on investments, especially in companies that demonstrate continued growth and potential.
MVM Partners manages a concentrated portfolio and typically invests between $20 million and $100 million per company, indicating a significant fund size focused on healthcare.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.